Quantcast

Keryx (KERX) Looks Good: Stock Adds 7.2% in Session


Shutterstock photo

Keryx Biopharmaceuticals, Inc. KERX was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.57 -$3.24 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen one positive estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Keryx. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Keryx currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Keryx Biopharmaceuticals, Inc. Price

Keryx Biopharmaceuticals, Inc. Price | Keryx Biopharmaceuticals, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Alexion Pharmaceuticals, Inc. ALXN , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is KERX going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>




Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Keryx Biopharmaceuticals, Inc. (KERX): Free Stock Analysis Report

Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , Investing Ideas , Stocks
Referenced Symbols: ALXN




More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research










Research Brokers before you trade

Want to trade FX?